Screener
Collegium Pharmaceutical, Inc. COLL Gross Carrying Amount
Gross Carrying Amount at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | June 30, 2026 / Cost | June 30, 2026 / Accumulated Amortization | June 30, 2026 / Carrying Amount | December 31, 2025 / Cost | December 31, 2025 / Accumulated Amortization | December 31, 2025 / Carrying Amount |
|---|---|---|---|---|---|---|
| Jornay PM | $635,000 | $(152,986) | $482,014 | $635,000 | $(111,072) | $523,928 |
| Azstarys | 635,000 | (7,480) | 627,520 | — | — | — |
| Belbuca | 360,000 | (322,305) | 37,695 | 360,000 | (284,607) | 75,393 |
| Nucynta Products | 521,170 | (521,170) | — | 521,170 | (493,478) | 27,692 |
| Symproic | 70,000 | (31,145) | 38,855 | 70,000 | (27,503) | 42,497 |
| Total intangible assets | $2,221,170 | $(1,035,086) | $1,186,084 | $1,586,170 | $(916,660) | $669,510 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s gross carrying amount?
- Collegium Pharmaceutical, Inc. (COLL) reported gross carrying amount of $2.22B in Q2 2026.
- What does gross carrying amount mean?
- Gross Carrying Amount
Ask your AI about Collegium Pharmaceutical, Inc.'s gross carrying amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude